Patrice P. Cacoub

Patrice P. Cacoub

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 417 publications

Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.

Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.

Journal: Circulation

Published: August 29, 2026

PDE4 inhibitor mitigates activated CD8+ T cells through NF-κB signaling in Behçet's syndrome.

PDE4 inhibitor mitigates activated CD8+ T cells through NF-κB signaling in Behçet's syndrome.

Journal: Frontiers in immunology

Published: March 19, 2026

Diagnostic accuracy of 18F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP).

Diagnostic accuracy of 18F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP).

Journal: European journal of nuclear medicine and molecular imaging

Published: March 02, 2026

Long-term outcomes and prognosis of mixed cryoglobulinaemia: a European multicentre study of 1294 patients.

Long-term outcomes and prognosis of mixed cryoglobulinaemia: a European multicentre study of 1294 patients.

Journal: Rheumatology (Oxford, England)

Published: January 26, 2026

Long-term outcomes and prognosis of mixed cryoglobulinemia: a European multicenter study of 1,294 patients.

Long-term outcomes and prognosis of mixed cryoglobulinemia: a European multicenter study of 1,294 patients.

Journal: Rheumatology (Oxford, England)

Published: January 26, 2026

Clonal haematopoiesis of indeterminate potential and relapses in patients with GCA.

Clonal haematopoiesis of indeterminate potential and relapses in patients with GCA.

Journal: Rheumatology (Oxford, England)

Published: January 12, 2026

Takayasu arteritis phenotypes and outcomes: A data-driven cluster analysis from a large international cohort.

Takayasu arteritis phenotypes and outcomes: A data-driven cluster analysis from a large international cohort.

Journal: Journal of autoimmunity

Published: January 06, 2026

Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experience.

Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experience.

Journal: RMD open

Published: December 19, 2025

Long Term Outcomes in Patients With Non-Infectious Mixed Cryoglobulinemic Vasculitis.

Long Term Outcomes in Patients With Non-Infectious Mixed Cryoglobulinemic Vasculitis.

Journal: American journal of hematology

Published: November 19, 2025

Stroke characteristics in giant cell arteritis and Takayasu arteritis: A multicenter retrospective cohort study of 108 patients.

Stroke characteristics in giant cell arteritis and Takayasu arteritis: A multicenter retrospective cohort study of 108 patients.

Journal: Seminars in arthritis and rheumatism

Published: November 02, 2025

Prognosis and Long-Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis.

Prognosis and Long-Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 20, 2025

Adalimumab, Anakinra, and Tocilizumab in Patients With Noninfectious Uveitis: A Multicenter Randomized Controlled Trial.

Adalimumab, Anakinra, and Tocilizumab in Patients With Noninfectious Uveitis: A Multicenter Randomized Controlled Trial.

Journal: American journal of ophthalmology

Published: September 16, 2025

Showing 1-12 of 417

Last Updated: 09/26/2026